SCHEMBL9048554

SCHEMBL9048554

CCOC(OCC)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC[C@@H]1CCc2ccccc2C1

nearest known ligand 0.52

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PREP P48147 17/20 0.52
F2 P00734 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9048561 1.00 PREP (0.52) PREPF2CHRM2CHRM4CHRM1
SCHEMBL9049450 0.95 PREP (0.50) PREP
SCHEMBL9049444 0.95 PREP (0.50) PREP
SCHEMBL9049236 0.91 PREP (0.56) PREPF2
SCHEMBL9045767 0.91 PREP (0.65) PREP
SCHEMBL9048739 0.91 PREP (0.65) PREP
SCHEMBL9049232 0.91 PREP (0.56) PREPF2
SCHEMBL9049424 0.91 PREP (0.56) PREPF2
SCHEMBL9048742 0.91 PREP (0.65) PREP
SCHEMBL9049428 0.91 PREP (0.56) PREPF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed